PLC Resources has identified a large, previously unmapped gold target at its Abbotts North project in WA after a new survey ...
Atlantic Media Group PLC will assess the carbon footprint of each participating production and support WDF's methane ...
Serco Awarded $109 Million CMS CERT Contract, Extending Support of Medicare Program Integrity The CMS CERT program is a vital ...
Board of Directors has resolved to launch a new stock option program for Nightingale Health’s or its group companies’ employees or other key persons. The purpose of Nightingale Health’s stock option ...
Bunzl is grateful to be recognized as a Diamond Status supplier and for its commitment to serving OECM’s 72 school boards, 24 ...
Good day, and welcome to Accenture's Third Quarter Fiscal 2026 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded. I'd now like to turn the conference over ...
Why don't we get started and maybe people will come in after. Yes, I'm happy to kick off the -- actually the first section, mostly autos today on this track with Aptiv, we have Kevin Clark, the CEO; ...
The Flexible Plastic Packaging Market is poised for sustained growth, driven by rising demand from the food & beverage, healthcare, personal care, and e-commerce sectors. Leading players are strengthe ...
CODESYS virtual safety solution uses software verification to meet industrial safety standards without expensive certified ...
DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells' capacity to fix their own damaged DNA, are growing well beyond the poly ADP ribose polymerase (“PARP”) ...
The Manila Times on MSN
Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
Consolidated closing of recently announced $5.5 million PIPE led by existing investors, combined with an additional $2.8 million in proceeds from warrant exercises, results in approximately $8.3 ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the completion of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results